Pharmaceutical Firms Receive Penalties for Various Violations

Published: 2005-02-04 06:58:00

Updated: 2005-02-04 06:58:00

Based on the 4th quarter 2004 pharmaceutical inspection report by Kyungin Regional Korea Food and Drug Administration (RKFDA), many of major domestic pharmaceutical firms received administrative penalties for a variety of violations discovered.

With a total number of 32 manufacturers listed, the report details major violations in the area of inappropriate labeling, misleading indications, no...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.